Cargando…
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
BACKGROUND: Pure mucinous carcinoma (PMC) is a rare type of breast cancer, estimated to represent 2% of invasive breast cancer. PMC is typically positive for estrogen receptors (ER) and progesterone receptors (PR) and negative for human epidermal growth factor receptor 2 (HER2). The clinicopathologi...
Autores principales: | Jang, Yunjeong, Jung, Hera, Kim, Han-Na, Seo, Youjeong, Alsharif, Emad, Nam, Seok Jin, Kim, Seok Won, Lee, Jeong Eon, Park, Yeon Hee, Cho, Eun Yoon, Cho, Soo Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986976/ https://www.ncbi.nlm.nih.gov/pubmed/31718120 http://dx.doi.org/10.4132/jptm.2019.10.24 |
Ejemplares similares
-
Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis
por: Bae, Soo Youn, et al.
Publicado: (2011) -
Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer
por: Yim, Hyun Ee, et al.
Publicado: (2021) -
Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
por: Jang, Yunjeong, et al.
Publicado: (2019) -
PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis
por: Seo, Youjeong, et al.
Publicado: (2018) -
The Prognostic Impact of Synchronous Ipsilateral Multiple Breast Cancer: Survival Outcomes according to the Eighth American Joint Committee on Cancer Staging and Molecular Subtype
por: Chu, Jinah, et al.
Publicado: (2018)